IMPL - Impel NeuroPharma GAAP EPS of -$1.27 misses by $0.49 revenue of $4.37M misses by $0.63M
2023-05-12 08:24:21 ET
- Impel NeuroPharma press release ( NASDAQ: IMPL ): Q1 GAAP EPS of -$1.27 misses by $0.49 .
- Revenue of $4.37M (+142.8% Y/Y) misses by $0.63M .
For further details see:
Impel NeuroPharma GAAP EPS of -$1.27 misses by $0.49, revenue of $4.37M misses by $0.63M